Impact of Hormone Receptor Status on Development of Brain Metastases from HER2+Breast Cancer

被引：0
|
作者：
Sachar, S. [1 ]
Chen, E. [2 ]
Harris, E. E. [2 ]
Montero, A. J. [3 ]
Choi, S. [4 ]
机构：
[1] Touro Coll Osteopath Med, New York, NY USA
[2] Univ Hosp Seidman Canc Ctr, Dept Radiat Oncol, Cleveland, OH USA
[3] Univ Hosp Cleveland Med Ctr, Cleveland, OH USA
[4] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2022年 / 114卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2138
引用
收藏
页码：E62 / E63
页数：2
相关论文
共 50 条
  • [1] Impact of Hormone Receptor Status on the Behaviour of HER2+Breast Cancer
    Kolarova, Iveta
    Dusek, Ladislav
    Ryska, Ales
    Odrazka, Karek
    Dolezel, Martin
    Vanasek, Jaroslav
    Melichar, Bohuslav
    Petera, Jiri
    Buchler, Tomas
    Vosmik, Milan
    Petrakova, Katarina
    Terarova, Petra
    Vilasova, Zdena
    Jarkovsky, Jiri
    IN VIVO, 2020, 34 (06): : 3441 - 3449
  • [2] Breast cancer bone metastases: The impact of decalcification in Hormone Receptor (HR) and HER-2 status
    Felizardo, D.
    Coimbra, N.
    Sarmento, T.
    Vieira, J.
    Afonso, N.
    Leal, C.
    Bartosch, C.
    Afonso, M.
    VIRCHOWS ARCHIV, 2013, 463 (02) : 256 - 256
  • [3] Comparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer.
    Tomasevic, Z.
    Milovanovic, Z.
    Tomasevic, Z. M.
    Skender, M.
    Pupic, G.
    Kovac, Z.
    Grujicic, D.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [4] Evolving management of HER2+breast cancer brain metastases and leptomeningeal disease
    Mills, Matthew N.
    King, Whitney
    Soyano, Aixa
    Pina, Yolanda
    Czerniecki, Brian J.
    Forsyth, Peter A.
    Soliman, Hatem
    Han, Hyo S.
    Ahmed, Kamran A.
    JOURNAL OF NEURO-ONCOLOGY, 2022, 157 (02) : 249 - 269
  • [5] Survival after brain metastases in Asian patients with HER2+breast cancer
    Yap, Y. S.
    Devi, B. C.
    Khorprasert, C.
    Cornelio, G. H.
    Sutandyo, N.
    Yeoh, E.
    Landis, S.
    Kobayashi, M.
    Moon, H.
    Ro, J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [6] Prognostic impact of extracranial disease control in HER2+breast cancer-related brain metastases
    Bottosso, Michele
    Griguolo, Gaia
    Sinoquet, Lea
    Guarascio, Maria Cristina
    Aldegheri, Vittoria
    Miglietta, Federica
    Vernaci, Grazia
    Barbieri, Caterina
    Girardi, Fabio
    Jacot, William
    Guarneri, Valentina
    Darlix, Amelie
    Dieci, Maria Vittoria
    BRITISH JOURNAL OF CANCER, 2023, 128 (07) : 1286 - 1293
  • [7] Prognostic impact of extracranial disease control in HER2+breast cancer-related brain metastases
    Bottosso, M.
    Griguolo, G.
    Sinoquet, L.
    Guarascio, M. C.
    Aldegheri, V.
    Miglietta, F.
    Barbieri, C.
    Girardi, F.
    Jacot, W.
    Guarneri, V.
    Darlix, A.
    Dieci, M. V.
    ANNALS OF ONCOLOGY, 2022, 33 (07) : S647 - S647
  • [8] CLINICOPATHOLOGICAL EVALUATION OF BRAIN METASTASES RECURRENCE IN METASTATIC HER2+BREAST CANCER PATIENTS
    Gasol Cudos, Ariadna
    Morales Murillo, Serafin
    Velasco Sanchez, Ana
    Serrate Lopez, Ana
    Aguirre Ortega, Elena
    Panades Siurana, Maria Jose
    Salud Salvia, Antonieta
    BREAST, 2013, 22 : S51 - S51
  • [9] Targeting HER2+Breast Cancer Brain Metastases: A Review of Brain-Directed HER2-Directed Therapies
    Chiec, Lauren
    Kumthekar, Priya
    CNS DRUGS, 2022, 36 (02) : 167 - 179
  • [10] Experts' opinion: Recommendations for retesting breast cancer metastases for HER2 and hormone receptor status
    Penault-Llorca, Frederique
    Coudry, Renata A.
    Hanna, Wedad M.
    Osamura, Robert Y.
    Rueschoff, Josef
    Viale, Giuseppe
    BREAST, 2013, 22 (02): : 200 - 202
12345